Literature DB >> 33782084

Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection.

Jenny A Doust1, Katy J L Bell2, Mariska M G Leeflang3, Jacqueline Dinnes4,5, Sally J Lord6, Sue Mallett7, Janneke H H M van de Wijgert8,9, Sverre Sandberg10,11, Khosrow Adeli12,13, Jonathan J Deeks4,5, Patrick M Bossuyt3, Andrea R Horvath2,14,15.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33782084     DOI: 10.1136/bmj.n568

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).

Authors:  Ke Zhou; Jean-Luc Raoul; Audrey Blanc-Lapierre; Valérie Seegers; Michèle Boisdron-Celle; Marianne Bourdon; Hakim Mahammedi; Aurélien Lambert; Camille Moreau-Bachelard; Mario Campone; Thierry Conroy; Frédérique Penault-Llorca; Martine M Bellanger; Frédéric Bigot
Journal:  Clin Med Insights Oncol       Date:  2022-04-18

2.  A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era.

Authors:  Sean C Taylor
Journal:  J Clin Virol Plus       Date:  2021-10-08

3.  SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis.

Authors:  Jonathan J Deeks; Anika Singanayagam; Hamish Houston; Alice J Sitch; Seran Hakki; Jake Dunning; Ajit Lalvani
Journal:  BMJ       Date:  2022-02-23

4.  Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study.

Authors:  Roderick P Venekamp; Irene K Veldhuijzen; Karel G M Moons; Wouter van den Bijllaardt; Suzan D Pas; Esther B Lodder; Richard Molenkamp; Zsofi Igloi; Constantijn Wijers; Claudy Oliveira Dos Santos; Sylvia B Debast; Marjan J Bruins; Khaled Polad; Carla R S Nagel-Imming; Wanda G H Han; Janneke H H M van de Wijgert; Susan van den Hof; Ewoud Schuit
Journal:  BMC Med       Date:  2022-02-24       Impact factor: 8.775

5.  Exploring beyond the limit: How comparative stochastic performance affects retesting outcomes in six commercial SARS CoV-2 nucleic acid amplification tests.

Authors:  Hiu Tat Chan; Marco H T Keung; Ivy Nguyen; Ellen L O Ip; Su M Chew; Danielle Siler; Marion Saville; David Hawkes
Journal:  J Clin Virol Plus       Date:  2022-04-30

6.  Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia.

Authors:  John Tembo; Nkongho Franklyn Egbe; Kwitaka Maluzi; Kangwa Mulonga; Moses Chilufya; Nathan Kapata; Victor Mukonka; Edgar Simulundu; Alimuddin Zumla; Sombo Fwoloshi; Lloyd Mulenga; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Matthew Bates
Journal:  Int J Infect Dis       Date:  2022-04-12       Impact factor: 12.074

7.  Evaluation of the artus® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction.

Authors:  Robert William O'Hara; Benjamin Brown; Angela Hughes; Ashley McEwan; Andrew Birtles; Adam Hawker; Emma Davies; Hamzah Z Farooq; Peter Tilston; Dominic Haigh; Louise Hesketh; Andrew Dodgson; Kirsty Dodgson; Ahmad Shazaad; Malcolm Guiver; Nicholas Machin
Journal:  J Clin Virol Plus       Date:  2022-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.